Del Nido cardioplegia in adult cardiac surgery - Scopes and concerns

Perfusion (United Kingdom)

Volumn 31, Issue 1, 2016, Pages 6-14

  Valooran, George Jose ^a   Nair, Shiv Kumar ^a   Chandrasekharan, Krishnan ^a   Simon, Rahul ^a   Dominic, Cyril ^a  

^a RAJAGIRI HOSPITAL   (India)

Author keywords

adult cardiac surgery; cardioplegia; del Nido; diastolic arrest; myocardial protection

Indexed keywords

CALCIUM; CARDIOPLEGIC AGENT; DEL NIDO CARDIOPLEGIC SOLUTION; GLUCOSE; INSULIN; POTASSIUM; UNCLASSIFIED DRUG;

ARTIFICIAL EMBOLISM; ATRIAL FIBRILLATION; CARDIOPLEGIA; CRYSTALLOID; DEFIBRILLATION; DISEASE CONTROL; DRUG DELIVERY SYSTEM; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART SURGERY; HUMAN; MEMBRANE STABILIZATION; NONHUMAN; OPERATION DURATION; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; ADOLESCENT; ADULT; CARDIOPULMONARY BYPASS; CHILD; HEART ARREST; PRESCHOOL CHILD; PROCEDURES; TRENDS;

ADOLESCENT; ADULT; CARDIOPULMONARY BYPASS; CHILD; CHILD, PRESCHOOL; HEART ARREST, INDUCED; HUMANS;

EID: 84949494224     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115608936     Document Type: Review

References (41)

1. Bigelow WG, Lindsay WK, Greenwood WF,. Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg 1950; 132: 849-866.
2. Melrose DG, Dieger DB, Bentall HH, et al. Elective cardiac arrest. Lancet 1955; 266: 21-23.
3. Scott T, Swanevelder J,. Perioperative myocardial protection. Contin Educ Anaesth Crit Care Pain 2009; 9: 97-101.
4. Brazier J, Cooper N, Buckberg GD,. The adequacy of subendocardial oxygen delivery: the interaction of determinants of flow, arterial oxygen content and myocardial oxygen need. Circulation 1974; 49: 968-977.
5. Garbade J, Davierwala P, Seeburger J, et al. Myocardial protection during minimally invasive mitral valve surgery: strategies and cardioplegic solutions. Ann Cardiothorac Surg 2013; 2: 803-808.
6. Kim JT, Park YH, Chang YE, et al. The effect of cardioplegic solution-induced sodium concentration fluctuation on postoperative seizure in pediatric cardiac patients. Ann Thorac Surg 2011; 91: 1943-1948.
7. Kaul TK, Fields BL,. Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg 2000; 8: 1-9.
8. Matte GS, del Nido PJ,. History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 2012; 44: 98-103.
9. Yerebakan H, Sorabella RA, Najjar M, et al. del Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison. J Cardiothorac Surg 2014; 9: 141
10. Yano Y, Braimbridge MV, Hearse DJ,. Protection of the pediatric myocardium. Differential susceptibility to ischemic injury of the neonatal rat heart. J Thorac Cardiovasc Surg 1987; 94: 887-896.
11. Drinkwater DC, Laks H,. Pediatric cardioplegic techniques. Sem Thorac Cardiovasc Surg 1993; 5: 168-175.
12. Lopaschuk GD, Wambolt RB, Barr RL,. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts. J Pharmacol Exp Ther 1993; 264: 135-144.
13. Grosso MA, Banerjee A, St.Cyr JA, et al. Cardiac 5'-nucleotidase activity increases with age and inversely relates to recovery from ischemia. J Thorac Cardiovasc Surg 1992; 103: 206-209.
14. Dobson GP,. Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery. J Thorac Cardiovasc Surg 2010; 140: 1213-1217.
15. Buckberg GD,. Antegrade/retrograde blood cardioplegia to ensure cardioplegic distribution: operative techniques and objectives. J Card Surg 1989; 4: 216-238.
16. Aldea GS, Hou D, Fonger JD, et al. Inhomogenous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 1994; 107: 499-504.
17. Honkonen EL, Kaukinen L, Pehkonen EJ, et al. Myocardial cooling and right ventricular function in patients with right coronary artery disease: antegrade vs. retrograde cardioplegia. Acta Anaesthesiol Scand 1997; 41: 287-296.
18. Siegenthaler MP,. Antegrade administration of cardioplegia. Multimed Man Cardiothorac Surg 2005; doi: 10.1510/mmcts.2004.000695.
19. Kempsford RD, Hearse DJ,. Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg 1989; 97: 856-863.
20. Watanabe H, Yokosawa T, Eguchi S, et al. Functional and metabolic protection of the neonatal myocardium from ischemia. Insufficient protection by cardioplegia. J Thorac Cardiovasc Surg 1989; 97: 50-58
21. Sternbergh WC, Brunsting LA, Abd-Elfattah AS, et al. Basal metabolic energy requirements of polarized and depolarized arrest in rat heart. Am J Physiol 1989; 256: H846-H851.
22. Loberman D, Neely RC, Fitzgerald D, et al. Modified del Nido cardioplegia in adult cardiac surgery; safety and efficacy. J Cardiol Curr Res 2014, 1: 00042.
23. von Oppell UO, Du Toit EF, King LM, et al. St. Thomas' Hospital cardioplegic solution. Beneficial effect of glucose and multidose reinfusions of cardioplegic solution. J Thorac Cardiovasc Surg 1991; 102: 405-412.
24. Lessen R, DiCapua J, Pekmezaris R, et al. Our experience with two cardioplegic solutions: dextrose versus non-dextrose in adult cardiac surgery. J Extra Corpor Technol 2012; 44: 134-138.
25. Gandhi GY, Nuttall GA, Abel MD, et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 2005; 80: 862-866.
26. Rizoli S,. Plasmalyte. J Trauma 2011; 70: S17-S18.
27. Davies PG, Venkatesh B, Morgan TJ, et al. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution. Crit Care 2011; 15: R21
28. Baraka A, Hirt N, Dabbous A, et al. Lidocaine cardioplegia for prevention of reperfusion ventricular fibrillation. Ann Thorac Surg 1993; 55: 1529-1533.
29. Sloots KL, Vinten-Johansen J, Dobson GP,. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery. J Thorac Cardiovasc Surg 2007; 133: 1171-1178.
30. Bito A, Inoue K, Asano M, Ando S, Takaba T,. Experimental myocardial preservation study of adding perfluorochemicals (FC43) in lidocaine cardioplegia. Jpn J Thorac Cardiovasc Surg 2000; 48: 280-290.
31. Govindapillai A, Hua R, Rose R, et al. Protecting the aged heart during cardiac surgery: use of Del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg 2013; 146: 940-948.
32. Sunamori M, Amano J, Okamura T, et al. Superior action of magnesium-lidocaine-1-aspartate cardioplegia to glucose-insulin-potassium cardioplegia in experimental myocardial protection. Jap J Surg 1982; 12: 372-380.
33. Charette K, Gerrah R, Quaegebeur J, et al. Single dose myocardial protection utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion 2012; 27: 98-103.
34. Mick SL, Robich MP, Houghtaling PL, et al. del Nido versus Buckberg cardioplegia in adult isolated valve surgery. J Thorac Cardiovasc Surg 2015; 149: 626-636.e5
35. Sorabella RA, Akashi H, Yerebakan H, et al. Myocardial protection using Del Nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg 2014; 29: 445-449.
36. Ramanathan R, Parrish DW, Armour TK, et al. Del Nido cardioplegia in adult cardiac surgery associated with fewer cardioplegia doses and defibrillations: potential benefits in minimally invasive valve surgery. In: AATS Mitral Conclave Conference 2013. New York, USA, May 2-3, 2013, E14, New York: AATS Mitral Conclave 2013.
37. Kim K, Ball C, Grady P, et al. Use of Del Nido cardioplegia for adult cardiac surgery at the Cleveland Clinic: perfusion implications. J Extra Corpor Technol 2014; 46: 317-323.
38. Stammers AH, Vang SN, Mejak BL, et al. Quantification of the effect of altering hematocrit and temperature on blood viscosity. J Extra Corpor Technol 2003; 35: 143-151.
39. Lucas SK, Elmer EB, Flaherty JT, et al. Effect of multiple-dose potassium cardioplegia on myocardial ischemia, return of ventricular function, and ultrastructural preservation. J Thorac Cardiovasc Surg 1980; 80: 102-110.
40. Sellke FW, Shafique T, Ely DL, et al. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals. Circulation 1993; 88: II395-400.
41. Yaghoubi A, Danaee S, Imani S, et al. Effect of citrate phosphate dextrose solution on reperfusion injury in coronary artery bypass surgical patients undergoing cardiopulmonary bypass. J Cardiovasc Thorac Res 2011; 3: 123-127.